KD Cort 30 Tablet contains Deflazacort 30mg, a synthetic corticosteroid with potent anti-inflammatory and immunosuppressive properties. It is primarily indicated for the management of various inflammatory and autoimmune conditions, including rheumatoid arthritis, systemic lupus erythematosus, allergic reactions, and certain muscular dystrophies. Deflazacort exerts its therapeutic effects by modulating the immune response and reducing the release of inflammatory mediators, thereby alleviating symptoms such as swelling, redness, and pain. The 30mg dosage strength is typically prescribed based on the severity of the condition and patient response, with gradual dose adjustments to minimize potential adverse effects. KD Cort 30 Tablet should be administered under strict medical supervision, as prolonged use may lead to side effects such as adrenal suppression, osteoporosis, hyperglycemia, and increased susceptibility to infections. Patients are advised to adhere to the prescribed regimen and avoid abrupt discontinuation to prevent withdrawal symptoms. Monitoring of blood pressure, blood glucose levels, and bone density is recommended during long-term therapy. KD Cort 30 Tablet is contraindicated in patients with systemic fungal infections and known hypersensitivity to corticosteroids. Caution is warranted in individuals with diabetes, hypertension, or peptic ulcer disease.